Cite
Zegard A, Okafor O, de Bono J, et al. Greyzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction >35. Europace. 2021;doi: 10.1093/europace/euab167.
Zegard, A., Okafor, O., de Bono, J., Kalla, M., Lencioni, M., Marshall, H., Hudsmith, L., Qiu, T., Steeds, R., Stegemann, B., & Leyva, F. (2021). Greyzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction >35. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, . https://doi.org/10.1093/europace/euab167
Zegard, Abbasin, et al. "Greyzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction >35." Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology vol. (2021). doi: https://doi.org/10.1093/europace/euab167
Zegard A, Okafor O, de Bono J, Kalla M, Lencioni M, Marshall H, Hudsmith L, Qiu T, Steeds R, Stegemann B, Leyva F. Greyzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction >35. Europace. 2021 Aug 11; doi: 10.1093/europace/euab167. Epub 2021 Aug 11. PMID: 34379762.
Copy
Download .nbib